Related Experiment Video
Updated: Jul 13, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas
Alberto Valbuena1, Ana Suárez-Gauthier, Fernando López-Rios
1Programa de Oncología Translacional, Instituto de Biología Molecular y Celular del Cáncer, CSIC, Universidad de Salamanca, Spain.
Abstract:
Human VRK1 (vaccinia-related kinase 1) is a novel serine-threonine kinase that regulates several transcription factors, including p53, ATF2 and c-Jun; and its loss results in defects of cell proliferation. VRK1 stabilizes p53 and the accumulated p53 downregulates VRK1 forming an autoregulatory loop. Wild-type p53, but not mutant p53, was able to downregulate VRK1 in the A549 lung carcinoma cell line. VRK1 expression has been studied in human lung carcinomas. VRK1 protein level was significantly higher in squamous cell lung carcinomas than in adenocarcinomas, and inversely correlated with p16. Tumours with p53 mutations have a positive trend with those having very high levels of VRK1 protein, particularly in squamous cell lung carcinomas. These data indicate that the VRK1-p53 autoregulatory loop was not functional in a group of lung carcinomas. The accumulation of VRK1 in tumours with mutant p53 could result in stimulation of other signalling pathways that can contribute to tumour growth and progression in addition to those resulting from loss of p53 function.
Insights
Vaccinia-related kinase 1 (VRK1) protein levels are elevated in lung carcinomas, particularly with p53 mutations. This suggests a disrupted VRK1-p53 autoregulatory loop contributes to tumor growth.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Human VRK1 (vaccinia-related kinase 1) is a serine-threonine kinase regulating transcription factors like p53, ATF2, and c-Jun.
- VRK1 stabilizes p53, which in turn downregulates VRK1, forming an autoregulatory loop.
Purpose of the Study:
- To investigate VRK1 expression in human lung carcinomas.
- To determine the functionality of the VRK1-p53 autoregulatory loop in lung cancer.
Main Methods:
- Analysis of VRK1 protein levels in lung carcinoma tissues.
- Correlation of VRK1 expression with p53 mutation status and p16 expression.
Main Results:
- VRK1 protein levels were significantly higher in squamous cell lung carcinomas compared to adenocarcinomas.
- A positive trend was observed between high VRK1 protein levels and p53 mutations, especially in squamous cell lung carcinomas.
- VRK1 expression inversely correlated with p16 levels.
Conclusions:
- The VRK1-p53 autoregulatory loop is non-functional in a subset of lung carcinomas.
- Accumulated VRK1 in tumors with mutant p53 may promote tumor growth and progression through alternative signaling pathways.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

